Register for Belay’s Industry Sponsored Symposium at SNO 2026
2,360 CSF Liquid Biopsy Cases. What can we learn from the largest CSF liquid biopsy testing to date?
Date
Time
7:00–8:15 amEastern Time
Breakfast will be provided
About the session
Join us at SNO as Chetan Bettegowda, MD, PhD, director of the Johns Hopkins Department of Neurosurgery, and Alexandra Miller, MD, co-director of NYU Langone’s Brain and Spine Tumor Center, explore the mountain of evidence and new findings from this unprecedented cohort.
Dr. Bettegowda will open with an overview of the science and clinical evidence supporting CSF ctDNA testing in CNS disease.
Dr. Miller will present findings from a retrospective analysis of 2,549 CSF specimens representing 2,360 unique real-world cases, including 137 cases with longitudinal testing.
The presentations will explore the evidence supporting CSF liquid biopsy and what this large-scale analysis reveals about molecular testing in primary and metastatic CNS disease.
Bring your questions and join us for the discussion.
Seating is limited. Reserve your spot today.
Featured speakers
Chetan Bettegowda, MD, PhD
Johns Hopkins Medicine
- Director, Department of Neurosurgery
- Harvey Cushing Professor of Neurosurgery
- Neurosurgeon-in-Chief, The Johns Hopkins Hospital
- Director, Reza Khatib Brain Tumor Center
- Director, Comprehensive Brain Tumor Center
- Co-Director, Trigeminal Neuralgia Center
- Director, Physician Scientist Training Program, Johns Hopkins University School of Medicine
- Medical Director, Ludwig Center for Cancer Genetics and Therapeutics
Alexandra Miller, MD
NYU Langone Health
- Chief, Neuro-Oncology Program
- Co-Director, Brain and Spine Tumor Center (BSTC)
